167 related articles for article (PubMed ID: 37712059)
1. Early expansion of activated adaptive but also exhausted NK cells during acute severe SARS-CoV-2 infection.
Claus M; Pieris N; Urlaub D; Bröde P; Schaaf B; Durak D; Renken F; Watzl C
Front Cell Infect Microbiol; 2023; 13():1266790. PubMed ID: 37712059
[TBL] [Abstract][Full Text] [Related]
2. Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2.
Saini P; Adeniji OS; Bordoloi D; Kinslow J; Martinson J; Parent DM; Hong KY; Koshy J; Kulkarni AJ; Zilberstein NF; Balk RA; Moy JN; Giron LB; Tracy RP; Keshavarzian A; Muthumani K; Landay A; Weiner DB; Abdel-Mohsen M
mBio; 2023 Feb; 14(1):e0339322. PubMed ID: 36728420
[TBL] [Abstract][Full Text] [Related]
3. Natural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications.
Di Vito C; Calcaterra F; Coianiz N; Terzoli S; Voza A; Mikulak J; Della Bella S; Mavilio D
Front Immunol; 2022; 13():888248. PubMed ID: 35844604
[TBL] [Abstract][Full Text] [Related]
4. NK cells from COVID-19 positive patients exhibit enhanced cytotoxic activity upon NKG2A and KIR2DL1 blockade.
Lee G; Schauner R; Burke J; Borocz J; Vasana S; Sobieraj L; Giraudo M; Jackson Z; Ansari Q; Navas M; Sakr H; Wald D
Front Immunol; 2023; 14():1022890. PubMed ID: 37483595
[TBL] [Abstract][Full Text] [Related]
5. Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregates.
Malengier-Devlies B; Filtjens J; Ahmadzadeh K; Boeckx B; Vandenhaute J; De Visscher A; Bernaerts E; Mitera T; Jacobs C; Vanderbeke L; Van Mol P; Van Herck Y; Hermans G; Meersseman P; Wilmer A; Gouwy M; Garg AD; Humblet-Baron S; De Smet F; Martinod K; Wauters E; Proost P; Wouters C; Leclercq G; Lambrechts D; Wauters J; Matthys P
Front Immunol; 2022; 13():861251. PubMed ID: 36275702
[TBL] [Abstract][Full Text] [Related]
6. NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals.
Cuapio A; Boulouis C; Filipovic I; Wullimann D; Kammann T; Parrot T; Chen P; Akber M; Gao Y; Hammer Q; Strunz B; Pérez Potti A; Rivera Ballesteros O; Lange J; Muvva JR; Bergman P; Blennow O; Hansson L; Mielke S; Nowak P; Söderdahl G; Österborg A; Smith CIE; Bogdanovic G; Muschiol S; Hellgren F; Loré K; Sobkowiak MJ; Gabarrini G; Healy K; Sällberg Chen M; Alici E; Björkström NK; Buggert M; Ljungman P; Sandberg JK; Aleman S; Ljunggren HG
Mol Med; 2022 Feb; 28(1):20. PubMed ID: 35135470
[TBL] [Abstract][Full Text] [Related]
7. NK cell receptor and ligand composition influences the clearance of SARS-CoV-2.
Hsieh WC; Lai EY; Liu YT; Wang YF; Tzeng YS; Cui L; Lai YJ; Huang HC; Huang JH; Ni HC; Tsai DY; Liang JJ; Liao CC; Lu YT; Jiang L; Liu MT; Wang JT; Chang SY; Chen CY; Tsai HC; Chang YM; Wernig G; Li CW; Lin KI; Lin YL; Tsai HK; Huang YT; Chen SY
J Clin Invest; 2021 Nov; 131(21):. PubMed ID: 34720095
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Spike 1 Protein Controls Natural Killer Cell Activation via the HLA-E/NKG2A Pathway.
Bortolotti D; Gentili V; Rizzo S; Rotola A; Rizzo R
Cells; 2020 Aug; 9(9):. PubMed ID: 32859121
[TBL] [Abstract][Full Text] [Related]
9. NK cells in COVID-19-from disease to vaccination.
Hammer Q; Cuapio A; Bister J; Björkström NK; Ljunggren HG
J Leukoc Biol; 2023 Oct; 114(5):507-512. PubMed ID: 36976012
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cell-mediated ADCC in SARS-CoV-2-infected individuals and vaccine recipients.
Hagemann K; Riecken K; Jung JM; Hildebrandt H; Menzel S; Bunders MJ; Fehse B; Koch-Nolte F; Heinrich F; Peine S; Schulze Zur Wiesch J; Brehm TT; Addo MM; Lütgehetmann M; Altfeld M
Eur J Immunol; 2022 Aug; 52(8):1297-1307. PubMed ID: 35416291
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets.
Matic S; Popovic S; Djurdjevic P; Todorovic D; Djordjevic N; Mijailovic Z; Sazdanovic P; Milovanovic D; Ruzic Zecevic D; Petrovic M; Sazdanovic M; Zornic N; Vukicevic V; Petrovic I; Matic S; Karic Vukicevic M; Baskic D
PLoS One; 2020; 15(12):e0241097. PubMed ID: 33382687
[TBL] [Abstract][Full Text] [Related]
12. NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19.
Bergantini L; d'Alessandro M; Cameli P; Cavallaro D; Gangi S; Cekorja B; Sestini P; Bargagli E
Cells; 2021 Nov; 10(11):. PubMed ID: 34831404
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cell exhaustion in SARS-CoV-2 infection.
Gallardo-Zapata J; Maldonado-Bernal C
Innate Immun; 2022 Aug; 28(6):189-198. PubMed ID: 35733383
[TBL] [Abstract][Full Text] [Related]
14. NK Cell Subpopulations and Receptor Expression in Recovering SARS-CoV-2 Infection.
Saresella M; Trabattoni D; Marventano I; Piancone F; La Rosa F; Caronni A; Lax A; Bianchi L; Banfi P; Navarro J; Bolognesi E; Zanzottera M; Guerini FR; Clerici M
Mol Neurobiol; 2021 Dec; 58(12):6111-6120. PubMed ID: 34453271
[TBL] [Abstract][Full Text] [Related]
15. Defining the role of natural killer cells in COVID-19.
Lee MJ; Blish CA
Nat Immunol; 2023 Oct; 24(10):1628-1638. PubMed ID: 37460639
[TBL] [Abstract][Full Text] [Related]
16. Coordinated Loss and Acquisition of NK Cell Surface Markers Accompanied by Generalized Cytokine Dysregulation in COVID-19.
Ustiuzhanina MO; Vavilova JD; Boyko AA; Streltsova MA; Kust SA; Kanevskiy LM; Sapozhnikov AM; Iskhakov RN; Gubernatorova EO; Drutskaya MS; Bychinin MV; Zhukova OA; Novikova ON; Sotnikova AG; Yusubalieva GM; Baklaushev VP; Kovalenko EI
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768315
[TBL] [Abstract][Full Text] [Related]
17. Persistent Exhausted T-Cell Immunity after Severe COVID-19: 6-Month Evaluation in a Prospective Observational Study.
Vazquez-Alejo E; Tarancon-Diez L; Espinar-Buitrago MS; Genebat M; Calderón A; Pérez-Cabeza G; Magro-Lopez E; Leal M; Muñoz-Fernández MÁ
J Clin Med; 2023 May; 12(10):. PubMed ID: 37240647
[TBL] [Abstract][Full Text] [Related]
18. Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice.
Ghasemzadeh M; Ghasemzadeh A; Hosseini E
Hum Immunol; 2022 Jan; 83(1):86-98. PubMed ID: 34583856
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Value of Natural Killer Cells, CD56+ CD16+ Natural Killer Cells,
Radandish M; Esmaeil N; Khorvash F; Andalib A
Viral Immunol; 2022 Nov; 35(9):616-628. PubMed ID: 36099205
[TBL] [Abstract][Full Text] [Related]
20. An Evaluation of Type 1 Interferon Related Genes in Male and Female-Matched, SARS-CoV-2 Infected Individuals Early in the COVID-19 Pandemic.
Huecksteadt TP; Myers EJ; Aamodt SE; Trivedi S; Warren KJ
Viruses; 2024 Mar; 16(3):. PubMed ID: 38543837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
